New Hematologic Response Criteria Predict Survival in Patients With Immunoglobulin Light Chain Amyloidosis Treated With High-Dose Melphalan and Autologous Stem-Cell Transplantation Reply

Palladini Giovanni<sup>*</sup>; Dispenzieri Angela; Gertz Morie A; Kumar Shaji; Wechalekar Ashutosh; Hawkins Philip N; Schoenland Stefan; Hegenbart Ute; Comenzo Raymond; Kastritis Efstathios; Dimopoulos Meletios A; Jaccard Arnaud; Klersy Catherine; Merlini Giampaolo

doi:10.1200/JCO.2013.49.2512

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

New Hematologic Response Criteria Predict Survival in Patients With Immunoglobulin Light Chain Amyloidosis Treated With High-Dose Melphalan and Autologous Stem-Cell Transplantation Reply

作者：Palladini Giovanni^*; Dispenzieri Angela; Gertz Morie A; Kumar Shaji; Wechalekar Ashutosh; Hawkins Philip N; Schoenland Stefan; Hegenbart Ute; Comenzo Raymond; Kastritis Efstathios; Dimopoulos Meletios A; Jaccard Arnaud; Klersy Catherine; Merlini Giampaolo

来源：Journal of Clinical Oncology, 2013, 31(21): 2750-2751.

DOI：10.1200/JCO.2013.49.2512